SQZ Biotechnologies Co·4

Feb 15, 5:15 PM ET

Sharei Armon 4

4 · SQZ Biotechnologies Co · Filed Feb 15, 2022

Insider Transaction Report

Form 4
Period: 2022-02-10
Sharei Armon
DirectorPresident and CEO
Transactions
  • Award

    Stock Option

    2022-02-10+395,000395,000 total
    Exercise: $6.57Exp: 2032-02-09Common Stock (395,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying securities on February 10, 2023 and in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION